ANASTASIA FLOROS: Open Payments
NPI 1275948432 · CARLETON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 73 payments from 12 companies in 2025. Trend: 2023 $1,147 · 2024 $1,141 · 2025 $1,165
Food & beverage: $1,165
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $241 |
| Novo Nordisk Inc | 11 | $191 |
| ABBVIE INC. | 8 | $176 |
| Lilly USA, LLC | 14 | $159 |
| Indivior Inc. | 6 | $103 |
| Braeburn Inc. | 3 | $64 |
| Exact Sciences Corporation | 3 | $63 |
| PFIZER INC. | 3 | $52 |
| Viatris Specialty LLC | 2 | $46 |
| Actelion Pharmaceuticals US, Inc. | 2 | $33 |
Products named: CAPLYTA, VRAYLAR, MOUNJARO, SUBLOCADE, Rybelsus, Ozempic, BRIXADI, Wegovy.
Industry payments across MI — which companies pay providers there.
